Browsing by Author Brunet i Serra, Mercè
Showing results 1 to 11 of 11
Issue Date | Title | Author(s) |
---|---|---|
25-Jul-2019 | A pharmacogenetic intervention for the improvement of the safety profile of antipsychotic treatments | Arranz, María Jesús; González Rodríguez, Alexandre; Pérez Blanco, Josefina; Penadés Rubio, Rafael; Gutiérrez, Blanca; Ibáñez Lladó, Laura; Arias Sampériz, Bárbara; Brunet i Serra, Mercè; Cervilla, Jorge; Salazar, Juliana; Catalán, Rosa |
3-Jul-2021 | Advantages of plasmatic CXCL-10 as a prognostic and diagnostic biomarker for the risk of rejection and subclinical rejection in kidney transplantation | Millán, Olga; Rovira, Jordi; Guirado, Lluis; Espinosa, Cristina; Budde, Klemens; Sommerer, Claudia; Piñeiro, Gaston J.; Diekmann, Fritz; Brunet i Serra, Mercè |
2012 | Clinical pharmacokinetics of mycophenolic acid and its metabolites in solid organ transplant recipient | Colom Codina, Helena; Lloberas Blanch, Núria; Caldés, Ana; Andreu, Franc; Torras Ambròs, Joan; Oppenheimer Salinas, Federico; Sánchez-Plumed, Jaime; Gentil, Miguel A.; Kuypers, Dirk R.; Brunet i Serra, Mercè; Ekberg, Henrik; Grinyó Boira, Josep M. |
22-Jan-2021 | Early prognostic performance of miR155-5p monitoring for the risk of rejection: Logistic regression with a population pharmacokinetic approach in adult kidney transplant patients | Quintairos Domenech, Luis; Colom Codina, Helena; Millán, Olga; Fortuna, Virginia; Espinosa, Cristina; Guirado, Lluís; Budde, Klemens; Sommerer, Claudia; Lizana, Ana; López Púa, Yolanda; Brunet i Serra, Mercè |
9-Dec-2022 | Impact of Early Intrapatient Variability of Tacrolimus Concentrations on the Risk of Graft-Versus-Host Disease after Allogeneic Stem Cell Transplantation Using High-Dose Post-Transplant Cyclophosphamide | Marco, Daniel N.; Salas. Maria Queralt; Gutiérrez García, Gonzalo; Monge Escartín, Inés; Riu, Gisela; Carcelero, Esther; Roma, Joan Ramon; Llobet, Noemí; Arcarons, Jordi; Suárez Lledó, María; Martínez, Nuria; Pedraza, Alexandra; Domenech, Ariadna; Rosiñol, Laura; Fernández Avilés, Francesc; Urbano Ispizua, Álvaro; Rovira, Montserrat; Brunet i Serra, Mercè; Martínez, Carmen |
1-Jan-1985 | Metodologia analítica en les intoxicacions agudes | Rodamilans Pérez, Miguel; Guevara Ortiz de Pinedo, A.; Marquès Alamo, J.; Brunet i Serra, Mercè; Pou Fernández, Jordi |
Jan-2022 | miRNA-155-5p, miRNA-181a-5p, and miRNA-122-5p as prognostic biomarkers of clinical graft evolution in liver transplant patients | Marone Millà, Eva |
24-Apr-2019 | Monitoring of miR-181a-5p and miR-155-5p Plasmatic Expression as Prognostic Biomarkers for Acute and Subclinical Rejection in de novo Adult Liver Transplant Recipients. | Millán López, Olga; Ruiz, P.; Orts, Lara; Ferré Aparicio, Paula; Crespo, Gonzalo; Santana, Miguel; Fortuna, Virginia; Quintairos Domenech, Luis; Navasa, Miquel; Brunet i Serra, Mercè |
8-Jul-2021 | Population pharmacokinetic-pharmacodynamic modeling in solid organ transplantation: Basis of personalized immunosuppression | Quintairos Domenech, Luis |
29-Nov-2011 | Population Pharmacokinetics of Mycophenolic Acid (MPA) and its Metabolites (MPAG and AcMPAG) (Seminaris de Recerca 2011) | Colom Codina, Helena; Lloberas Blanch, Núria; Caldés, Ana; Andreu, Franc; Oppenheimer Salinas, Federico; Sánchez-Plumed, Jaime; Gentil, Miguel A.; Kuypers, Dirk R.; Brunet i Serra, Mercè; Ekberg, Henrik; Grinyó Boira, Josep M. |
24-Jun-2020 | The influence of CYP enzymes and ABCB1 on treatment outcomes in schizophrenia: association of CYP1A2 activity with adverse effects | Cendrós, Marc; Arranz, María Jesús; Torra, Mercè; Penadés Rubio, Rafael; Gonzalez-Rodriguez A; Brunet i Serra, Mercè; Pérez Blanco, Josefina; Ibáñez Lladó, Laura; Serra, Àlex; Catalán, Rosa |